This podcast describes how Managed Access Programs can continue treatment access for patients coming out of registration or other clinical trials who need to transition to commercial supply.
Thought Leaders: Suzanne Gagnon, MD, Chief Medical Officer, Idis, Karen Searle PhD, Study Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development and Michelle Gee, PhD, Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development
Play podcast
Showing posts with label Eisai. Show all posts
Showing posts with label Eisai. Show all posts
Subscribe to:
Posts (Atom)